Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
about
Plasticity of Candida albicans BiofilmsCandida albicans Biofilms and Human DiseasenBioChip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream Applications.Future therapies targeted towards eliminating Candida biofilms and associated infections.Updates on Therapeutic Strategies Against Candida (and Aspergillus) Biofilm Related Infections.
P2860
Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
@ast
Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
@en
type
label
Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
@ast
Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
@en
prefLabel
Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
@ast
Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
@en
P2093
P2860
P356
P1476
Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.
@en
P2093
Anand K Ramasubramanian
Anand Srinivasan
C Mauli Agrawal
Celia Macias Gupta
Jose L Lopez-Ribot
Kai P Leung
P2860
P304
P356
10.1002/BIT.25120
P577
2013-10-18T00:00:00Z